11.6
%Fund | ₹ 10000 |
FD | ₹ 10600 |
Amount Invested | Fund Value | Profit | Returns | |
---|---|---|---|---|
Fund | 120,000 | 116,426 | -3,574 | -6.45 |
Benchmark | 110,000 | 102,211 | -7,789 | -14.08 |
Scheme Name | Inception Date | 1 Year Return % | 2 Year Return % | 3 Year Return % | 5 Year Return % | 10 Year Return % |
---|---|---|---|---|---|---|
Tata Nifty MidSmall Healthcare Index Fund - Regular Plan - IDCW Reinvestment | 26-04-2024 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund - Regular Plan - Growth | 12-10-2022 | 11.35 | 9.88 | 0.0 | 0.0 | 0.0 |
HDFC Nifty G-Sec Jun 2036 Index Fund - Growth Option | 15-03-2023 | 11.04 | 9.65 | 0.0 | 0.0 | 0.0 |
Nippon India Nifty G-Sec Jun 2036 Maturity Index Fund-Regular Plan-Growth Option | 14-12-2022 | 11.0 | 9.61 | 0.0 | 0.0 | 0.0 |
SBI CRISIL IBX Gilt Index - June 2036 Fund - Regular Plan - Growth | 05-10-2022 | 10.85 | 9.46 | 0.0 | 0.0 | 0.0 |
Sector | Allocation (%) |
---|---|
Healthcare | 100.08 |
Company | Holdings (%) |
---|---|
MAX HEALTHCARE INSTITUTE LIMITED EQ | 14.84 |
LUPIN LIMITED EQ NEW F.V. RS.2/- | 9.38 |
FORTIS HEALTHCARE LIMITED. EQ | 6.52 |
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 6.04 |
ALKEM LABORATORIES LIMITED EQ | 5.04 |
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 4.86 |
LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 4.24 |
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 3.93 |
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.76 |